Outcomes related to IGFBP-7 in patients with heart failure and reduced ejection fraction and effects of dapagliflozin: findings from DAPA-HF

被引：0
|
作者：
Adamson, C. [1 ]
Welsh, P. [1 ]
Morrow, D. A. [2 ]
Docherty, K. F. [1 ]
Hammarstedt, A. [3 ]
Inzucchi, S. E. [4 ]
Kober, L. [5 ]
Kosiborod, M. N. [6 ]
Martinez, F. A. [7 ]
Ponikowski, P. [8 ]
Sabatine, M. S. [2 ]
Solomon, S. D. [2 ]
Sattar, N. [1 ]
Jhund, P. S. [1 ]
McMurray, J. J. V. [1 ]
机构：
[1] Univ Glasgow, Glasgow, Lanark, Scotland
[2] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[3] AstraZeneca, Gothenburg, Sweden
[4] Yale Univ, New Haven, CT USA
[5] Copenhagen Univ Hosp, Rigshosp, Copenhagen, Denmark
[6] Univ Missouri, Kansas City, KS USA
[7] Natl Univ Cordoba, Cordoba, Argentina
[8] Wroclaw Med Univ, Wroclaw, Poland
来源：
EUROPEAN HEART JOURNAL | 2022年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：913 / 913
页数：1
相关论文
共 50 条
  • [31] Efficacy and Safety of Dapagliflozin According to Frailty in Heart Failure With Reduced Ejection Fraction A Post Hoc Analysis of the DAPA-HF Trial
    Butt, Jawad H.
    Dewan, Pooja
    Merkely, Bela
    Belohlavek, Jan
    Drozdz, Jaroslaw
    Kitakaze, Masafumi
    Inzucchi, Silvio E.
    Kosiborod, Mikhail N.
    Martinez, Felipe A.
    Tereshchenko, Sergey
    Ponikowski, Piotr
    Bengtsson, Olof
    Lindholm, Daniel
    Langkilde, Anna Maria
    Schou, Morten
    Sjostrand, Mikaela
    Solomon, Scott D.
    Sabatine, Marc S.
    Chiang, Chern-En
    Docherty, Kieran F.
    Jhund, Pardeep S.
    Kober, Lars
    McMurray, John J. V.
    ANNALS OF INTERNAL MEDICINE, 2022, 175 (06) : 820 - +
  • [32] The relationships between circulating biomarkers of iron deficiency and outcomes in patients with heart failure and reduced ejection fraction: insights from DAPA-HF
    Docherty, Kieran
    Brennan, Alice
    Sukumar, Shivasankar
    Welsh, Paul
    Ponikowski, Piotr
    Petrie, Mark
    Cleland, John
    Solomon, Scott
    Jhund, Pardeep
    McMurray, John
    CIRCULATION, 2024, 150
  • [33] Sex Differences in Characteristics, Outcomes, and Treatment Response With Dapagliflozin Across the Range of Ejection Fraction in Patients With Heart Failure: Insights From DAPA-HF and DELIVER
    Wang, Xiaowen
    Vaduganathan, Muthiah
    Claggett, Brian L.
    Hegde, Sheila M.
    Pabon, Maria
    Kulac, Ian J.
    Vardeny, Orly
    O'Meara, Eileen
    Zieroth, Shelley
    Katova, Tzvetana
    McGrath, Martina M.
    Pouleur, Anne-Catherine
    Jhund, Pardeep S.
    Desai, Akshay S.
    Inzucchi, Silvio E.
    Kosiborod, Mikhail N.
    de Boer, Rudolf A.
    Kober, Lars
    Sabatine, Marc S.
    Martinez, Felipe A.
    Ponikowski, Piotr
    Shah, Sanjiv J.
    Hernandez, Adrian F.
    Langkilde, Anna Maria
    McMurray, John J., V
    Solomon, Scott D.
    Lam, Carolyn S. P.
    CIRCULATION, 2023, 147 (08) : 624 - 634
  • [34] DAPA-HF: does dapagliflozin provide 'bang for your buck' as a treatment forheart failure with reduced ejection fraction?
    Cowie, Martin R.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (11) : 2157 - 2159
  • [35] DAPAGLIFLOZIN USE IN HEART FAILURE WITH REDUCED EJECTION FRACTION PATIENTS: A SINGLE CENTRE COMPARISON BETWEEN REAL-LIFE AND DAPA-HF DATA
    Capovilla, Teresa Maria
    Mapelli, Massimo
    Mattavelli, Irene
    Salvioni, Elisabetta
    Marongiu, Alessandro
    Maranzano, Gaspare
    Vignati, Carlo
    Palermo, Pietro
    Sinagra, Gianfranco
    Agostoni, Piergiuseppe
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24
  • [36] Reply to 'The 50 shades of bilirubin'. Letter regarding the article 'Liver tests and outcomes in heart failure with reduced ejection fraction: findings from DAPA-HF'
    Adamson, Carly
    Jhund, Pardeep S.
    McMurray, John J. V.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (11) : 2206 - +
  • [37] Initial Decline (Dip) in Estimatec Glomerular Filtration Rate After Initiation of Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction: Insights From DAPA-HF
    Adamson, Carly
    Docherty, Kieran F.
    Heerspink, Hiddo J. L.
    de Boer, Rudolf A.
    Damman, Kevin
    Inzucchi, Silvio E.
    Kober, Lars
    Kosiborod, Mikhail N.
    Martinez, Felipe A.
    Petrie, Mark C.
    Ponikowski, Piotr
    Sabatine, Marc S.
    Schou, Morten
    Solomon, Scott D.
    Verma, Subodh
    Bengtsson, Olof
    Langkilde, Anna Maria
    Sjostrand, Mikaela
    Vaduganathan, Muthiah
    Jhund, Pardeep S.
    McMurray, John J., V
    CIRCULATION, 2022, 146 (06) : 438 - 449
  • [38] The 50 shades of bilirubin. Letter regarding the article 'Liver tests and outcomes in heart failure with reduced ejection fraction: findings from DAPA-HF'
    Krawczyk, Marcin
    Boehm, Michael
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (11)
  • [39] Effects of dapagliflozin in DAPA-HF according to background heart failure therapy
    Docherty, Kieran F.
    Jhund, Pardeep S.
    Inzucchi, Silvio E.
    Kober, Lars
    Kosiborod, Mikhail N.
    Martinez, Felipe A.
    Ponikowski, Piotr
    DeMets, David L.
    Sabatine, Marc S.
    Bengtsson, Olof
    Sjostrand, Mikaela
    Langkilde, Anna Maria
    Desai, Akshay S.
    Diez, Mirta
    Howlett, Jonathan G.
    Katova, Tzvetana
    Ljungman, Charlotta E. A.
    O'Meara, Eileen
    Petrie, Mark C.
    Schou, Morten
    Verma, Subodh
    Pham Nguyen Vinh
    Solomon, Scott D.
    McMurray, John J., V
    EUROPEAN HEART JOURNAL, 2020, 41 (25) : 2379 - 2392
  • [40] The Dapagliflozin and Prevention of Adverse outcomes in Heart Failure trial (DAPA-HF) in context
    McMurray, John J. V.
    Solomon, Scott D.
    Docherty, Kieran F.
    Jhund, Pardeep S.
    EUROPEAN HEART JOURNAL, 2021, 42 (13) : 1199 - 1202
12345